Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 65 and up

Intranasal dexmedetomidine to stabilize blood pressure during cataract surgery in older adults

Official title: The Effect of Intranasal Dexmedetomidine Compared to Placebo on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery: A Double-Blind Randomized Controlled Trial

Run by Suez Canal University · NCT07080229 · Data updated 2026-11-12

This trial will test whether a single intranasal dose of dexmedetomidine given before cataract surgery helps control blood pressure in people aged 65 and older with hypertension.

More Hypertension trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages65 Years and up
SexAll
Enrollment126 (estimated)
SponsorSuez Canal University
Academic / other
Locations1 site (Ismailia, Ismailia Governorate)
StatusRecruiting
StartedJuly 16, 2025
Main results expectedApril 2026
Study endsMay 2026
Registry record updatedApril 7, 2026
Trial IDNCT07080229 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 65 or older with stage 2 hypertension who are scheduled for elective cataract surgery under local anesthesia and classified as ASA II or III.

Probably not a fit

Patients with significant baseline bradycardia (<50 bpm), arrhythmias, allergy to dexmedetomidine, current sedative/anxiolytic use, or severe hepatic, renal, or cerebrovascular disease are excluded and may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 interventional trial compares intranasal dexmedetomidine (1 mcg/kg ideal body weight, diluted to 1 mL and delivered with a mucosal atomization device, 0.5 mL per nostril) to matching intranasal saline given before peribulbar anesthesia for elective cataract surgery. A peribulbar block using lidocaine 2% and bupivacaine 0.5% is used for local anesthesia in all patients. The primary outcome is perioperative mean arterial pressure (MAP) with secondary outcomes including sedation quality and adverse events. Eligible participants are adults aged 65 or older with stage 2 hypertension and ASA physical status II or III.

Why it matters

Potential benefit: If successful, the approach could reduce perioperative blood pressure swings and lower the risk of cardiovascular complications while providing gentle sedation for older patients.

How similar studies have gone: Prior smaller studies have shown intranasal dexmedetomidine can provide sedation and help stabilize hemodynamics, but robust phase 3 evidence in elderly hypertensive cataract patients is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged ≥65 years.
2. Patients who will have stage 2 hypertension as per ACC/AHA guidelines (Systolic BP \> 140 and Diastolic BP\> 90 mmHg)
3. Elective cataract surgery under local anesthesia.
4. American Society of Anesthesiologists (ASA) physical status II or III.

Exclusion Criteria:

1. Allergy or contraindication to dexmedetomidine.
2. Significant baseline bradycardia (\<50 bpm) or arrhythmias.
3. Use of sedative or anxiolytic medications.
4. History of severe hepatic, renal, or cerebrovascular diseases.

Where it's running

  • Suez Canal University Hospitals
    Ismailia, Ismailia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Using low-dose aspirin after preeclampsia to improve recovery

    This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

    Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

  • Rotational Stability of the Acunex Vario Toric

    This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.

    Recruiting Vienna Institute for Research in Ocular Surgery · Vienna · NCT07925840

  • Anterior segment anatomy assessment with swept-source OCT in eye surgery patients

    This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.

    Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07903454

  • MiLOOP-assisted cataract surgery for dense cataracts

    In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.

    Recruiting Universiti Kebangsaan Malaysia Medical Centre · Cheras, Kuala Lumpur · NCT07898007

  • IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

    This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

    Recruiting at 8 sites Bahir Dar University · Ādēt and 7 other locations · NCT07894068

  • Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF

    This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.

    Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT07893821

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.